Up to this point, we seem to be able to explain, to a certain extent, why CPT1A acts as a tumor suppressor gene in renal clear cell carcinoma, instead of acting as an oncogene in ovarian cancer, leukemia, and colorectal cancer. Here, CPT1A is linked to ovarian carcinoma.